| 1 | [SID87336904] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID87336904] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 3 | [SID87336904] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 4 | [SID87336904] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 5 | [SID87336904] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 6 | [SID87336904] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 7 | [SID87336904] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 8 | [SID87336904] | Active | | | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID449763, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 449763 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID87336904] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 10 | [SID87336904] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 11 | [SID87336904] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 12 | [SID87336904] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID87336904] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID87336904] | Inactive | Potency | 0.1995 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | Potency | 0.1995 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 15 | [SID87336904] | Inactive | Potency | 0.1995 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | Potency | 0.1995 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID87336904] | Inactive | EC50 | 53 | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex [AID602473, Type: confirmatory] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | EC50 | 53 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 602473 | | BioAssay type | confirmatory | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 17 | [SID87336904] | Inactive | EC50 | 53 | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex [AID602473, Type: confirmatory] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | EC50 | 53 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 602473 | | BioAssay type | confirmatory | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 18 | [SID87336904] | Inactive | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 19 | [SID87336904] | Inactive | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 20 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 21 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 22 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 23 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 24 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 25 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 26 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 27 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 28 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 29 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 30 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 31 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 32 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 33 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 34 | [SID87336904] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 35 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 36 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 37 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 38 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 39 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 40 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 41 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 42 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 43 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 44 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 45 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 46 | [SID87336904] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 47 | [SID87336904] | Inactive | | | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651636, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651636 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 48 | [SID87336904] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 49 | [SID87336904] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 50 | [SID87336904] | Inactive | Potency | | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 87336904 | | CID | 44601683 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|